ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...

Over the last four years, weight-loss drugs that dampen down appetite and promote satiety have revolutionised obesity ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists.

Novo Nordisk has said a real-world survey of its weight-loss therapy Wegovy shows it can reduce 'food noise', persistent, ...

Novo Nordisk’s injectable amylin alternative to Wegovy appears to have underperformed the approved obesity blockbuster in a ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live ...

Indian markets could be overestimating US Fed rate cut impact, equity tag for REITs a step towards global best practices, ...

The new FDA program is "a perfect fit" for Lilly's pill, according to Citi Research analyst Geoffrey Meacham. The FDA, which ...

Serena Williams is noticeably slimmer now than she was when she retired from the WTA Tour in 2022. Last month she revealed how that happened.

The drugs could "significantly improve" weight loss in children but could also come with some serious consequences ...

Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched ...